Genera is a company with more than a hundred years of tradition and roots dating back to the foundation of the Royal Croatian-Slavonian Bacteriological Institute in 1901. It was part of the Croatian pharmaceutical company Pliva during the period 1940 to 2000, after this date it operated as an independent company, Veterina.
In October 2015, Dechra Pharmaceuticals PLC, a UK listed company, acquired 92.65% controlling interest in Genera dd. On 1 February 2018, Genera became a 100% subsidiary of the Dechra Group and it has subsequently delisted from the Zagreb Stock Exchange.
The broad portfolio of the Group includes animal health products, food supplements in the form of vitamins and minerals and plant protection products.
Genera holds GMP (Good Manufacturing Practice) certificates, which is a key indicator for the harmonization of the production processes and quality management systems with the strictest requirements of European regulatory authorities.
More about Dechra Pharmaceuticals PLC find here www.dechra.com
Company: Genera Incorporated for development and production of pharmaceuticals
Short name: Genera Inc.
Head Office: Kalinovica (Grad Sveta Nedjelja), Svetonedeljska cesta 2
Refistered Office: Registered in the Court register of the Commercial Court of Zagreb
Registered company number (MBS): 080369519
Company bank Account Number:
IBAN: HR 72 2484 0081 1004 8859 4 RBA, SWIFT RZBHHR2X
IBAN: HR 84 2360 0001 1015 2930 6 ZABA , SWIFT ZABAHR2X
Company ID Number (MB):1526782
Authorized Capital: HRK 166.037.400,00
Person authorized to represent the company: Anthony Gerard Griffin, President of the Management Board and CEO; Marko Fresl, Member of the Management Board.
Mladen Vedriš, President of the Supervisory Board.